Kevin Doody - 15 Jan 2022 Form 4 Insider Report for INVO Bioscience, Inc. (IVF)

Role
Medical Director, Director
Signature
/s/ Kevin Doody
Issuer symbol
IVF
Transactions as of
15 Jan 2022
Net transactions value
$0
Form type
4
Filing time
18 Jan 2022, 20:29:44 UTC
Next filing
03 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INVO Common Stock Award $0 +7,480 +4.4% $0.000000 177,306 15 Jan 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INVO Stock Option Award $0 +9,088 $0.000000 9,088 15 Jan 2022 Common Stock 9,088 $3.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in monthly increments over a period of twelve months from the date of grant.